Drug class in one race
PRMT5 drugs for Non-Small Cell Lung Cancer
4 tracked PRMT5 drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the PRMT5 page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
2 Phase 1/21 Phase 11 preclinical / unstaged